Xanthohumol Protects Against Neuronal Excitotoxicity and Mitochondrial Dysfunction in APP/PS1 Mice: An Omics-Based Study
Nutrients · 2024
DOI: 10.3390/nu16213754 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2024. Verfasst von Fei-Fei Hu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Hubei Provincial Clinical Research Center for Alzheimer's Disease, Wuhan University of Science and Technology, Wuhan 430065, China. Hauptthemen laut MEDLINE: Propiophenones, Flavonoids, Alzheimer Disease, Mitochondria. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Guangdong Project of Medical Science and Technology Research, Hubei Province Natural Science Foundation.
Abstract (Originalsprache)
Background
Neuronal excitotoxicity and metabolic decline, which begin in the early stages of Alzheimer’s disease (AD), pose challenges for effective amelioration. Our previous work suggested that the natural compound xanthohumol, the most abundant prenylated flavonoid in hops, prevents memory deficits in APP/PS1 mice; however, the underlying mechanisms remain unclear.
Methods
This study utilized APP/PS1 mice and cutting-edge omics techniques to investigate the effects of xanthohumol on hippocampal proteome, serum metabolome, and microbiome.
Results
Our findings revealed that xanthohumol reduces the postsynaptic overexpression of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid, N-methyl-D-aspartate, and metabotropic glutamate receptors, but enhances ATP synthesis and mitophagy in the young AD hippocampus. Further mechanistic analyses suggested systemic regulatory effects, particularly on the decreasing glutamate synthesis in the blood and intestines of AD mice following xanthohumol administration.
Conclusions
These results underscore the potential of xanthohumol in mitigating AD pathology through multifaceted mechanisms, sparking interest and curiosity in its preventive and therapeutic potential in AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hubei Provincial Clinical Research Center for Alzheimer's Disease, Wuhan University of Science and Technology, Wuhan 430065, China.
- Brain Science and Advanced Technology Institute, Medical School, Wuhan University of Science and Technology, Wuhan 430065, China.
- Shenzhen Center for Disease Control and Prevention, Shenzhen 518055, China.
ORCID-Profile: Fei-Fei Hu, Jian-Jun Liu
Förderung
- National Natural Science Foundation of China
- Guangdong Project of Medical Science and Technology Research
- Hubei Province Natural Science Foundation
- Shenzhen Key Medical Discipline Construction Fund
- Sanming Project of Medicine in Shenzhen
Zitieren
APA
Hu, F. F., Pan, S. Y., Chu, J. Y., Liu, J. J., Duan, T. T., Luo, Y., Zhou, W., Wang, Z. M., Liu, W., & Zeng, Y. (2024). Xanthohumol Protects Against Neuronal Excitotoxicity and Mitochondrial Dysfunction in APP/PS1 Mice: An Omics-Based Study. Nutrients. https://doi.org/10.3390/nu16213754
Vancouver
Hu FF, Pan SY, Chu JY, Liu JJ, Duan TT, Luo Y, et al. Xanthohumol Protects Against Neuronal Excitotoxicity and Mitochondrial Dysfunction in APP/PS1 Mice: An Omics-Based Study. Nutrients. 2024. doi:10.3390/nu16213754
BibTeX
@article{Hu2024,
author = {Hu, Fei-Fei and Pan, Shi-Yao and Chu, Jin-Yu and Liu, Jian-Jun and Duan, Ting-Ting and Luo, Yu and Zhou, Wen and Wang, Zhi-Ming and Liu, Wei and Zeng, Yan},
title = {Xanthohumol Protects Against Neuronal Excitotoxicity and Mitochondrial Dysfunction in APP/PS1 Mice: An Omics-Based Study},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16213754}
}
EUVIMED